We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential.

Luxembourg-based steelmaker ArcelorMittal is bringing on lobbying firepower as the steel conglomerate seeks to defend its control over a key Liberian railway corridor.

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...

Eli Lilly's Orforglipron shines in Phase III trials, potentially leading diabetes and obesity treatment by 2026. See what to ...

Northwestern University spinout Grove Biopharma, a synthetic biology specialist developing a platform known as Bionic ...

US biotech Grove Biopharma has secured $30 million in a series A round to move its lead program targeting advanced prostate ...

Wall Street’s Evan David Seigerman stirred the pot by slashing his price target on Eli Lilly stock—but not his enthusiasm.

Press Release Grove Biopharma, a private biotechnology company pioneering its Bionic Biologics™ platform to develop therapies targeting previously intractable intracellular disease targets, today ...

Duyk said the $30 million in funding has helped Grove Biopharma expand from "about four people working on this" to a current 10-person headcount and allowed it to move from Portal Innovations' labs to ...

Indiana Gov. Mike Braun announced on Tuesday he is planning to conduct an independent audit of all accounting associated with the Indiana Economic Development Corporation to ...

A clinical-stage biotech company developing bifunctional small-molecule therapeutics designed to eliminate disease-driving ...